I just got my Dr. To get genetic testing on my mucin tumors. Came back I have KRAS mutation. Anyone else with this...
Understanding Your KRAS Mutation in Appendiceal Cancer
I'm glad you advocated for genetic testing - that's an important step. KRAS mutations are found in approximately 40-50% of appendiceal mucinous tumors, so you're definitely not alone in having this finding.
What This Means for Treatment
The treatment landscape for KRAS-mutated appendiceal cancer is evolving, but I need to be direct with you: the specific KRAS variant matters significantly for treatment options.
The Key Question: Which KRAS Variant?
Your genetic testing report should specify which KRAS mutation you have. The most common variants in appendiceal cancer include:
- KRAS G12D (most common - about 34% of KRAS mutations)
- KRAS G12V (second most common)
- KRAS G12C (rare in appendiceal cancer - only 1-2%)
- KRAS G12R
- Other variants (G13D, Q61, etc.)
Why this matters: The KRAS G12C variant has FDA-approved targeted therapies (adagrasib/Krazati and sotorasib), but this variant is very rare in appendiceal cancer. According to NCCN Guidelines, these KRAS G12C inhibitors have shown response rates of 21-42% in gastrointestinal cancers, though most data comes from colorectal and pancreatic cancers.
Current Treatment Approaches
For non-G12C KRAS mutations (which is likely your situation):
Standard chemotherapy remains the primary approach, but research is actively developing new options:
-
Emerging KRAS-targeted therapies (clinical trials):
- MRTX1133 - targets KRAS G12D specifically
- RMC-6236 - targets multiple KRAS variants including G12D, G12V, G12R
- ASP3082 - a protein degrader targeting KRAS G12D
- Combination approaches with MEK inhibitors
-
Chemotherapy - Still the backbone of treatment for inoperable disease:
- FOLFOX or CAPOX regimens (often used in appendiceal cancer)
- May work differently depending on your KRAS status
-
Other biomarker-directed therapies - Your testing may have revealed additional actionable findings beyond KRAS
Critical Questions for Your Oncologist
-
"Which specific KRAS variant do I have?" (G12D, G12V, G12C, etc.)
-
"Are there clinical trials available for my specific KRAS mutation?"
- Specifically ask about trials for appendiceal cancer or gastrointestinal cancers with your variant
-
"Did my genetic testing reveal any other actionable mutations?"
- MSI-high status (opens immunotherapy options)
- BRCA1/2, PALB2 (opens PARP inhibitor options)
- HER2 amplification
- NTRK fusions (rare but highly treatable)
-
"Should I get more comprehensive genomic testing?"
- Tumor-only vs. tumor + germline testing
- RNA sequencing (can find fusions that DNA testing misses)
-
"What chemotherapy regimen do you recommend given my KRAS status?"
-
"Would you recommend getting a second opinion at a center specializing in appendiceal cancer?"
- Centers like MD Anderson, Memorial Sloan Kettering, or UCSF have appendiceal cancer expertise
The Bigger Picture
According to research presented at AACR conferences, KRAS has historically been considered "undruggable," but that's changing rapidly. The American Cancer Society notes that while KRAS mutations were once thought impossible to target, multiple new approaches are now in development.
For appendiceal cancer specifically: The treatment approach often depends more on whether your tumor is low-grade vs. high-grade mucinous, and whether you have peritoneal disease, than on KRAS status alone. KRAS status may help predict response to certain chemotherapies.
Next Steps
- Get the specific KRAS variant from your report - this is crucial
- Ask about comprehensive genomic profiling if you only had limited testing
- Search for clinical trials specific to your KRAS variant at ClinicalTrials.gov
- Consider a second opinion at an appendiceal cancer center of excellence
- Ask if your tumor should be tested for MSI/MMR status if not already done
The field is moving quickly - what wasn't available even 2 years ago may be available now or soon. Your oncologist will determine the most appropriate approach for YOUR specific case based on your complete clinical picture.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
- Has anyone had the genetic testing before chemotherapy that is called DYPD come back abnormal? Says that the chemo...
- Is there no hope even after surgery it came back. Chemo again. Isn't there something called-ablation
- I would like to hear from anyone who have or had tumor growth on their skin. * What kind of treatment are you...
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated November 13, 2026. Informational only — not a substitute for your oncology team.
Question asked:
I just got my Dr. [removed] get genetic testing on my mucin tumors. Came back I have KRAS mutation. Anyone else with this and was there a treatment option ? I am inoperable.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for Appendiceal cancer patients
Have your records handy? Add them to a private case for a deeper, personalized read →
More questions about Appendiceal cancer
- Anyone else experience severe body aches with keytruda
- Anyone else having bad side effects from immunotherapy
- Just got back from urgent Care first fall winter with nine Hopkins lymphoma low grade I have been ill three and a...
- Which biomarker tests (KRAS, BRCA1/2) are recommended for my Pancreatic Cancer, and how will the results guide my...
- Has anyone else experienced weakness on one side of their body after chemotherapy?"
- The Immunotherapy & Migraine Connection (Central Sensitisation) Has anyone else found that their migraines or...
- What is the first-line treatment for metastatic non-small cell lung cancer with no driver mutations
- Has anyone done BITE immunotherapy? If so what was it like? The chemo is done and lymphoma is already back five...